# Denosumab Sequential Therapy

> **NCT03868033** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 101 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT03868033
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868033, "Denosumab Sequential Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03868033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*